|
| Figure 1: Structure of endogenous cannabinoid agonists. The structure of the members of the endogenous cannabinoid lipid mediators (A) Anandamide (AEA),( B) 2-Arachidonoylglycerol (2AG), (C) Oleoylethanolamide (OEA), (D) Palmitoylethanolamide (PEA) and (E) virodhamine and (F) the exocannabinoid Δ9-Tetrahydrocannabinol (Δ9-THC). |
